易方达中证生物科技主题ETF(159837)利润分配表
| |
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
| 收入 |
99,003,493.66 |
-265,373,450.16 |
-366,470,109.07 |
-149,885,167.70 |
| 利息合计 |
15,670.42 |
694,807.86 |
637,903.89 |
2,460,467.79 |
| 其中：存款利息收入 |
15,670.42 |
48,102.02 |
24,758.01 |
79,446.41 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
-61,569,310.29 |
-199,460,798.38 |
-109,993,022.12 |
-210,995,677.65 |
| 其中：股票投资收益 |
-71,170,494.14 |
-218,722,492.49 |
-121,731,794.58 |
-231,147,757.53 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
- |
- |
- |
- |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
9,601,183.85 |
19,261,694.11 |
11,738,772.46 |
20,152,079.88 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
160,670,942.55 |
-67,505,053.85 |
-257,519,893.60 |
57,561,711.02 |
| 其他收入 |
-113,809.02 |
897,594.21 |
404,902.76 |
1,088,331.14 |
| 费用 |
1,442,407.78 |
2,940,838.45 |
1,501,076.55 |
3,657,285.65 |
| 管理人报酬 |
942,655.04 |
1,923,356.07 |
985,983.37 |
2,458,701.45 |
| 基金托管费 |
314,218.38 |
641,118.71 |
328,661.15 |
819,567.12 |
| 销售服务费 |
- |
- |
- |
- |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中：卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
185,534.36 |
374,035.00 |
184,224.26 |
370,445.00 |
| 利润总额 |
97,561,085.88 |
-268,314,288.61 |
-367,971,185.62 |
-153,542,453.35 |
微信公众号
证券之星APP
基本资料
